Prescription/Over the Counter Drug Screen, for Suspected Overdose, Serum




Test Mnemonic

BDRUG

CPT Codes

  • 80307 - QTY (1)

Aliases

  • Drug Screen, Prescription/OTC, Serum
  • Overdose Screen, Blood

Includes

  • Methsuximide
  • Salicylate
  • Zaleplon
  • Citalopram
  • Acetaminophen
  • Amitriptyline
  • Amobarbital
  • Brompheniramine
  • Bupropion
  • Butabarbital
  • Butalbital
  • Caffeine
  • Carbamazepine
  • Carisoprodol
  • Chlorpheniramine
  • Chlorpromazine
  • Clomipramine
  • Clozapine
  • Codeine
  • Cyclobenzaprine
  • Desipramine
  • Dextromethorphan
  • Diazepam
  • Diphenhydramine
  • Doxepin
  • Doxylamine
  • Fluoxetine
  • Guaifenesin
  • Ibuprofen
  • Imipramine
  • Lamotrigine
  • Levetiracetam
  • Lidocaine
  • Meperidine
  • Mephobarbital
  • Meprobamate
  • Metaxalone
  • Methadone
  • Methylphenidate
  • Midazolam
  • Mirtazapine
  • Naproxen
  • Nordiazepam
  • Nortriptyline
  • Oxcarbazepine metabolite
  • Pentobarbital
  • Phenobarbital
  • Phenytoin
  • Primidone
  • Promethazine
  • Secobarbital
  • Sertraline
  • Fentanyl
  • Strychnine
  • Tramadol
  • Trimipramine
  • Venlafaxine
  • Zolpidem
  • Topiramate
  • Trazodone
  • Valproic Acid

Performing Laboratory

Mayo Clinic Dpt of Lab Med & Pathology

FDA Category

Laboratory Developed Test


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
2.75 mLSerumNo additive (Red) RefrigeratedDo not draw serum separator tubes (SST). Separate serum from cells ASAP or within 2 hours of collection. Transfer serum to standard aliquot tube.

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1.1 mL     

Stability

Environmental Condition Description
Ambient3 hours
Refrigerated14 days
Frozen14 days

Days Performed

Mon - Sun

Turnaround Time

4 - 5 days

Methodology

Name Description
Gas Chromatography Mass Spectrometry (GCMS) 

Reference Range

Special Info

Cautions: Not intended for therapeutic compliance testing. Not intended for use in employment-related testing. Plasma or serum gel tubes will be rejected. This test is New York State approved.

Clinical Info

Useful for detection and identification of prescription or over the counter drugs frequently found in drug overdose or used with a suicidal intent. This test is designed to qualitatively identify drugs present in the specimen; quantification of identified drugs, when available, may be performed upon client request. Drugs of toxic significance that are not detected by this test are: Digoxin, lithium, and many drugs of abuse or illicit drugs, some benzodiazepines, and some opioids. Drugs detected are presumptive. Additional testing may be required to confirm the presence of any drugs detected.